- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Advanced breast cancer
- Meeting Date: November 2019
- Public Summary Document (PSD) November 2019 PBAC Meeting - (PDF 706KB)
- Public Summary Document (PSD) November 2019 PBAC Meeting - (Word 181KB)
Talazoparib – November 2019
Talazoparib: Capsule 250 micrograms (as tosilate), Capsule 1 mg (as tosilate); Talzenna®
Last updated
20 March 2020